pillbase.ru

Thyroid Liquescence 3021

Wirkstoff: FUCUS VESICULOSUS, IODINE, SPONGIA OFFICINALIS SKELETON, ROASTED, SKIM MILK, MOLYBDENUM, ENTEROBIUS VERMICULARIS, THYROID, UNSPECIFIED, CALCIUM HEXAFLUOROSILICATE, REDUCTIC ACID

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · FUCUS VESICULOSUS 4 [hp_X]/118mL, IODINE 4 [hp_X]/118mL, SPONGIA OFFICINALIS SKELETON, ROASTED 4 [hp_X]/118mL, SKIM MILK 6 [hp_X]/118mL, MOLYBDENUM 6 [hp_X]/118mL, ENTEROBIUS VERMICULARIS 6 [hp_X]/118mL, THYROID, UNSPECIFIED 6 [hp_X]/118mL, CALCIUM HEXAFLUOROSILICATE 8 [hp_X]/118mL, REDUCTIC ACID 8 [hp_X]/118mL

Vereinigte StaatenAktiv

Zulassungsinhaber: Professional Complementary Health Formulas

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • FUCUS VESICULOSUS · 4 [hp_X]/118mL
  • IODINE · 4 [hp_X]/118mL
  • SPONGIA OFFICINALIS SKELETON, ROASTED · 4 [hp_X]/118mL
  • SKIM MILK · 6 [hp_X]/118mL
  • MOLYBDENUM · 6 [hp_X]/118mL
  • ENTEROBIUS VERMICULARIS · 6 [hp_X]/118mL
  • THYROID, UNSPECIFIED · 6 [hp_X]/118mL
  • CALCIUM HEXAFLUOROSILICATE · 8 [hp_X]/118mL
  • REDUCTIC ACID · 8 [hp_X]/118mL
Zulassung
Zulassungsnummer
63083-3021
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen